. Efficacy and Safety of the Alpha7 Agonist Abt-126 as a Monotherapy Treatment in Mild-To-Moderate Alzheimer's Dementia: Results of a Phase 2b Trial. Alzheimers Dement. 2014 Jul;10 (4 Suppl):P137.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Nelonicline